$40.2M in CY2024 Part D spend854K claims · 717K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Cefpodoxime Proxetil used for?
Cefpodoxime Proxetil kills bacteria by disrupting cell wall synthesis, used for a range of infections.
Is there a generic for Cefpodoxime Proxetil?
Yes. 10 ANDAs filed at FDA, 4 generic manufacturers currently shipping.
How much does my plan pay for Cefpodoxime Proxetil?
Across 329 Part D plans, Cefpodoxime Proxetil averages $1.25/unit (NADAC). Lowest available: $1.06/unit. Highest in distribution: $1.46/unit.
Is Cefpodoxime Proxetil on the FDA shortage list?
No. Cefpodoxime Proxetil is not currently on the FDA Drug Shortage Database.
5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.